Eldridge Investment Advisors Inc. bought a new stake in Clorox Co (NYSE:CLX) during the fourth quarter, HoldingsChannel.com reports. The fund bought 4,335 shares of the company’s stock, valued at approximately $631,000. Clorox makes up about 0.5% of Eldridge Investment Advisors Inc.’s investment portfolio, making the stock its 29th biggest position.
Other institutional investors have also recently made changes to their positions in the company. Dupont Capital Management Corp acquired a new stake in Clorox in the 3rd quarter valued at approximately $199,000. Smith Moore & CO. acquired a new position in shares of Clorox during the 3rd quarter worth approximately $204,000. Private Asset Management Inc. acquired a new position in shares of Clorox during the 4th quarter worth approximately $208,000. Lourd Capital LLC acquired a new position in shares of Clorox during the 4th quarter worth approximately $210,000. Finally, Gratus Capital LLC acquired a new position in shares of Clorox during the 3rd quarter worth approximately $215,000. 73.42% of the stock is currently owned by institutional investors and hedge funds.
Clorox Co (CLX) opened at $131.70 on Friday. The company has a debt-to-equity ratio of 2.35, a quick ratio of 0.86 and a current ratio of 1.22. The firm has a market capitalization of $17,042.51, a P/E ratio of 23.82, a P/E/G ratio of 2.47 and a beta of 0.31. Clorox Co has a 1-year low of $124.09 and a 1-year high of $150.40.
Clorox (NYSE:CLX) last posted its earnings results on Friday, February 2nd. The company reported $1.23 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.43 billion. Clorox had a return on equity of 126.70% and a net margin of 13.21%. The firm’s revenue was up .7% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.14 EPS. analysts anticipate that Clorox Co will post 6.23 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 11th. Investors of record on Wednesday, April 25th will be issued a dividend of $0.96 per share. The ex-dividend date is Tuesday, April 24th. This is a positive change from Clorox’s previous quarterly dividend of $0.84. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.92%. Clorox’s payout ratio is presently 55.45%.
CLX has been the topic of several recent analyst reports. Zacks Investment Research raised Clorox from a “sell” rating to a “hold” rating in a research report on Monday, November 6th. Morgan Stanley lowered their price target on Clorox from $138.00 to $128.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 2nd. Consumer Edge raised Clorox from a “neutral” rating to an “outperform” rating in a research report on Friday, November 10th. Jefferies Group reaffirmed a “hold” rating and set a $132.00 price target on shares of Clorox in a research report on Wednesday, November 1st. Finally, Argus lowered Clorox from a “buy” rating to a “hold” rating and lowered their price target for the stock from $150.40 to $127.81 in a research report on Thursday, February 8th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $132.46.
In related news, SVP Michael R. Costello sold 10,574 shares of the business’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the transaction, the senior vice president now directly owns 34,867 shares of the company’s stock, valued at approximately $4,742,260.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.00% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “Eldridge Investment Advisors Inc. Takes Position in Clorox Co (CLX)” was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this piece of content can be viewed at https://ledgergazette.com/2018/02/18/eldridge-investment-advisors-inc-takes-position-in-clorox-co-clx.html.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.